Clearmind Medicine Inc. Net Foreign Exchange Loss
Clearmind Medicine Inc. (CMND) reported Net Foreign Exchange Loss of $3.68 thousand for the 12-month period ending 2023-10-31, per its 20-F/A filed 2024-03-18.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:NetForeignExchangeLoss · last filed 2024-03-18
- Clearmind Medicine Inc. net foreign exchange loss for the quarter ending 2023-01-31 was 365.24K CAD.
CAD
| Period end | Net Foreign Exchange Loss 3 month | Net Foreign Exchange Loss 12 month |
|---|---|---|
| 2023-01-31 | 365.24K CAD 6-K · filed 2023-03-17 | |
| 2022-10-31 | 45.60K CAD 20-F · filed 2023-02-06 |
USD
| Period end | Net Foreign Exchange Loss 6 month | Net Foreign Exchange Loss 12 month |
|---|---|---|
| 2023-10-31 | $3.68K 20-F/A · filed 2024-03-18 | |
| 2023-04-30 | $39.55K 6-K · filed 2023-06-14 |